HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activating brown adipose tissue for weight loss and lowering of blood glucose levels: a microPET study using obese and diabetic model mice.

AbstractPURPOSE:
This study aims at using 18F-FDG microPET to monitor the brown adipose tissue (BAT) glucose metabolism in obese and diabetic mouse models under different interventions, and study the therapeutic potential of BAT activation for weight loss and lowering of blood glucose in these models.
METHODS:
Obese mice were established by a high-fat diet for eight weeks, and diabetes mellitus(DM) models were induced with Streptozocin in obese mice. 18F-FDG microPET was used to monitor BAT function during obese and DM modeling, and also after BRL37344 (a β3-adrenergic receptor agonist) or levothyroxine treatment. The BAT function was correlated with the body weight and blood glucose levels.
RESULTS:
Compared with the controls, the obese mice and DM mice showed successively lower 18F-FDG uptake in the interscapular BAT (P = 0.036 and < 0.001, respectively). After two-week BRL37344 treatment, the BAT uptake was significantly elevated in both obese mice (P = 0.010) and DM mice (P = 0.004), accompanied with significantly decreased blood glucose levels (P = 0.023 and 0.036, respectively). The BAT uptake was negatively correlated with the blood glucose levels in both obese mice (r = -0.71, P = 0.003) and DM mice (r = -0.74, P = 0.010). BRL37344 treatment also caused significant weight loss in the obese mice (P = 0.001). Levothyroxine treatment increased the BAT uptake in the control mice (P = 0.025) and obese mice (P = 0.013), but not in the DM mice (P = 0.45).
CONCLUSION:
The inhibited BAT function in obese and DM mice can be re-activated by β3-adrenergic receptor agonist or thyroid hormone, and effective BAT activation may lead to weight loss and blood glucose lowering. Activating BAT can provide a new treatment strategy for obesity and DM.
AuthorsChenxi Wu, Wuying Cheng, Yi Sun, Yonghong Dang, Fengying Gong, Huijuan Zhu, Naishi Li, Fang Li, Zhaohui Zhu
JournalPloS one (PLoS One) Vol. 9 Issue 12 Pg. e113742 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25462854 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Insulin
  • Fluorodeoxyglucose F18
Topics
  • Adipose Tissue, Brown (drug effects, metabolism)
  • Animals
  • Blood Glucose
  • Diabetes Mellitus (metabolism, pathology, therapy)
  • Diabetes Mellitus, Experimental (metabolism, pathology, therapy)
  • Diet, High-Fat
  • Fluorodeoxyglucose F18 (administration & dosage, metabolism)
  • Humans
  • Insulin (metabolism)
  • Mice
  • Mice, Inbred NOD
  • Mice, Obese
  • Obesity (metabolism, pathology, therapy)
  • Positron-Emission Tomography
  • Weight Loss

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: